Clinical Application of the Medyria TrackCath System in Endovascular Repair of Abdominal Aortic Aneurysms (AAA)

Inclusion Criteria: * Patient has signed and understood the approved Informed Consent form and is able to meet the proposed study proceedings (CIP). * Patient is ≥18 years of age * Need for standard or complex EVAR of AAA according to the relevant guidelines: * Asymptomatic aneurysms with a diameter \> 55mm in men and \> 50 mm in woman * Aneurysm-growth exceeds 10mm/year * Patient requires at least one cannulation during which requires at least one cannulation (e.g. fenestration of endograft, side-branch and/or contralateral leg of endograft) Exclusion Criteria: * Patient is generally contraindicated for EVAR * Patient requires an emergency surgery * Patient with an increased risk of aneurysm rupture or saccular aneurysm, aneurysm with isolated wall protuberances or penetrating aortic ulcer * Patient with a dissecting acutely ruptured or leaking aneurysm or an acute vascular injury caused by a trauma * Patient with stroke or transient ischemic attack (TIA) within the last 6 months prior to baseline * Patient with myocardial infarction (MI) with the last 3 months prior to baseline * Patient with acute or chronic renal failure (including dialysis); Creatinine \> 2.00 mg/dl or \> 182 µmol/L * Patient with co-morbidities that constitutes an unacceptable risk (for example chronic obstructive pulmonary disease (COPD), liver failure, immunosuppression, polyneuropathy and hematological diseases) * Patient with bleeding history or coagulopathy * Patient with contraindication or allergies to take anticoagulants, antiplatelet drugs or contrast media * Life expectancy of less than 5 years * Female patient that is pregnant, is planning on becoming pregnant in the next month or is breastfeeding * Patient with inability to obtain vascular access * Patient has an active local or systemic infection * Patient is currently participating in another investigational study where the endpoints have not yet been achieved * Patient has a mental illness, and/or been diagnosed as clinically depressed or belongs to a vulnerable population (e.g., prisoner, severe drug abuser, developmentally disabled) that would compromise the ability to provide informed consent. * Patient has an obstructed or inadequate vasculature by means of tortuous anatomy hindering the TC catheter to reach target orifice(s) * Patient has an elevated risk of plaque dislodgment.